Literature DB >> 32329363

The role of 5-HT7 receptors on isoproterenol-induced myocardial infarction in rats with high-fat diet exacerbated coronary endothelial dysfunction.

I Cinar1, Z Halici2, B Dincer3, B Sirin2, E Cadirci2.   

Abstract

The presence of 5-HT7r's in both human and rat cardiovascular and immune tissues and their contribution to inflammatory conditions prompted us to hypothesize that these receptors contribute in acute myocardial infarction (MI) with underlying chronic endothelial dysfunction. We investigated the role of 5-HT7 receptors on heart tissue that damaged by isoproterenol (ISO)-induced MI in rats with high-fat diet (HFD). In vitro and in vivo effects of 5-HT7r agonist (LP44) and antagonist (SB269970) have been investigated on the H9C2 cell line and rats, respectively. For in vivo analyses, rats were fed with HFD for 8 weeks and after this period ISO-induced MI model has been applied to rat. To investigate the role of 5-HT7r's, two different doses of LP44 and SB269970 were evaluated and compared with standard hypolipidemic agent, atorvastatin. In vitro studies showed that LP44 has protective and proliferative effects on rat cardiomyocytes. Also in in vivo studies stimulating 5-HT7r's by LP44 improved blood lipid profile (decreased total cholesterol, low-density lipoprotein-C, and triglyceride, increased high-density lipoprotein), decreased cardiac damage markers (creatine kinase and troponin-I), and corrected inflammatory status (tumor necrosis factor-α, interleukin-6). Our results showed significant improvement in LP44 administered rats in terms of histopathologic analyses. In damaged tissues, 5-HT7 mRNA expression increased and agonist administration decreased this elevation significantly. We determined for the first time that 5-HT7r's are overexpressed in ISO-induced MI of rats with underlying HFD-induced endothelial dysfunction. Restoration of this overexpression by LP44, a 5-HT7r agonist, ameliorated heart tissue in physiopathologic, enzymatic, and molecular level, showing the cardiac role of these receptors and suggesting them as future potential therapeutic targets.

Entities:  

Keywords:  5-HT7 receptor; LP44; SB269970; hyperlipidemia; myocardial infarction; serotonin

Year:  2020        PMID: 32329363     DOI: 10.1177/0960327120916821

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

1.  Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats.

Authors:  Himanshu Verma; Anindita Bhattacharjee; Naveen Shivavedi; Prasanta Kumar Nayak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-25       Impact factor: 3.195

2.  5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues.

Authors:  Irfan Cinar; Busra Sirin; Zekai Halici; Saziye Sezin Palabiyik-Yucelik; Erol Akpinar; Elif Cadirci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-02-02       Impact factor: 3.000

3.  Effects of tocilizumab and dexamethasone on the downregulation of proinflammatory cytokines and upregulation of antioxidants in the lungs in oleic acid-induced ARDS.

Authors:  Funda Terzi; Beste Demirci; İrfan Çınar; Mohammad Alhilal; Huseyin Serkan Erol
Journal:  Respir Res       Date:  2022-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.